NATURAL SCIENCE CORPORATION OF AMERICA – Trademark Portfolio

Entity Type: 03

NATURAL SCIENCE CORPORATION OF AMERICA holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include PURACOL, PROSTA-NORM, and TRIPLE THERAPY. The owner is based in CALABASAS, CA.

23637 PARK CAPRI

SUITE 36

CALABASAS, CA 91302

12 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

NATURAL SCIENCE CORPORATION OF AMERICA's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (12 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does NATURAL SCIENCE CORPORATION OF AMERICA have?

NATURAL SCIENCE CORPORATION OF AMERICA has 12 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 8 cancelled.

What trademark classes does NATURAL SCIENCE CORPORATION OF AMERICA file in?

NATURAL SCIENCE CORPORATION OF AMERICA files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are NATURAL SCIENCE CORPORATION OF AMERICA's most well-known trademarks?

NATURAL SCIENCE CORPORATION OF AMERICA's registered trademark portfolio includes well-known marks such as PURACOL, PROSTA-NORM, and TRIPLE THERAPY. These are among 3 currently registered trademarks in the portfolio.

What is NATURAL SCIENCE CORPORATION OF AMERICA's trademark registration success rate?

NATURAL SCIENCE CORPORATION OF AMERICA has a 25% trademark registration rate, with 3 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.